0001193125-26-308041.txt : 20260717 0001193125-26-308041.hdr.sgml : 20260717 20260717174852 ACCESSION NUMBER: 0001193125-26-308041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260715 FILED AS OF DATE: 20260717 DATE AS OF CHANGE: 20260717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Webster Brian Daniel CENTRAL INDEX KEY: 0001877188 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42549 FILM NUMBER: 261184737 MAIL ADDRESS: STREET 1: 3933 LAKE WASHINGTON BLVD NE STREET 2: SUITE 200 CITY: KIRKLAND STATE: WA ZIP: 98033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KESTRA MEDICAL TECHNOLOGIES, LTD. CENTRAL INDEX KEY: 0001877184 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3933 LAKE WASHINGTON BLVD NE STREET 2: SUITE 200 CITY: KIRKLAND STATE: WA ZIP: 98033 BUSINESS PHONE: (425) 279-8002 MAIL ADDRESS: STREET 1: 3933 LAKE WASHINGTON BLVD NE STREET 2: SUITE 200 CITY: KIRKLAND STATE: WA ZIP: 98033 4 1 ownership.xml 4 X0609 4 2026-07-15 0001877184 KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS 0001877188 Webster Brian Daniel false 3933 LAKE WASHINGTON BLVD NE, SUITE 200 KIRKLAND WA 98033 true true false false See Remarks true Common Shares 2026-07-15 4 A false 176470 0.00 A 571937 D Common Shares 2026-07-15 2026-07-15 4 S false 11216 22.0105 D 560721 D Common Shares 2026-07-15 2026-07-15 4 S false 784 22.6333 D 559937 D Common Shares 2026-07-15 2026-07-15 4 S false 3000 23.9983 D 556937 D Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026. The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.45 to $22.44. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.45 to $23.00. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.49 to $24.10. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. President and Chief Executive Officer /s/ Brian Daniel Webster 2026-07-17